07 Jan 2001

Floradix® Multipretten® (Floradix® Multipretten® Kräuter-Dragees) - Deutschland

Updated: 07 Jan 2001

Floradix® Multipretten® Kräuter-Dragees

Erhaltung einer gesunden Magenfunktion und Förderung der Eiweißverdauung. Zum Schutz gegen Gasbildung, Blähungen, Völlegefühl und Magendruck.

Floradix® Multipretten® Description, Presentation and Dosage

Floradix® Multipretten® Description

Floradix® Multipretten® Drug Class Description

Andere Kombinationen

Floradix® Multipretten® Drug Description

1 Drg. enth.: Extr. Fruct. Carvi (spir. sicc.) 20 mg, Extr. Fruct. Foeniculi (spir. sicc.) 20 mg, Ol. Anisi (spir. sicc.) 20 mg, Extr. Fruct. Coriandri (spir. sicc.) 10 mg, Extr. Herba Absinthii (spir. sicc.) 30 mg, Extr. Fol. Menthae pip. (spir. sicc.) 20 mg, Extr. Herba Millefolii (spir. sicc.) 20 mg, Extr. Rad. Imperatoriae (spir. sicc.) 10 mg, Ol. Anisi (DAB) 0,8 mg, Ol. Carvi (DAB) 0,8 mg, Ol. Foeniculi (DAB) 0,8 mg, Ol. Menthae pip. (DAB) 0,8 mg, Ol. Coriandri 0,4 mg, Bromelaine 8 mg, Enzymgemisch aus Aspergillus Oryzae 20 mg entspr. einem Pankreatin 4 mal NF XIII pro Drg. Mindestgehalt von 0,003 ml an ätherischem Öl mit 0,8 mg Trans-Anethol u. 0,3 mg Carvon.

Floradix® Multipretten® Generic Name

Floradix® Multipretten® Kräuter-Dragees

Floradix® Multipretten® Presentation

Floradix® Multipretten® Presentation

Floradix® Multipretten® Kräuter-Dragees

Floradix® Multipretten® Manufacturer

Salushaus

Related Learning Zones

COPD Knowledge Centre

COPD Knowledge Centre

The COPD Knowledge Centre has been designed to provide healthcare professionals with free access to educational materials and disease awareness information. This includes information on the epidemiology, pathophysiology and symptoms of COPD and the latest guidelines for the diagnosis, treatment and management of the disease.

COPD-specific resources such as videosguidelinesinfographics, materials for your patients, upcoming events, useful websites and symposium videos and materials from ATS 2015 are available free of charge.

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Floradix® Multipretten® Dosage

Floradix® Multipretten® Adult Dosage

Talkum, Arabisches Gummi, Calciumcarbonat (E 170), E 171, Weißer Ton, Macrogol.

Floradix® Multipretten® Precautions, Reactions and Contraindications

Floradix® Multipretten® Special Precautions

Floradix® Multipretten® Special Precautions

A 97

Floradix® Multipretten® Adverse Reactions

Floradix® Multipretten® Adverse Reactions

F 5 a

Related Drugs - Gastroenterology

Back to top